Fair Value Measurements - Narrative (Details) $ in Thousands |
Jun. 30, 2026
USD ($)
|
Mar. 31, 2026
USD ($)
|
Dec. 31, 2025
USD ($)
|
Jun. 30, 2025
USD ($)
|
Mar. 31, 2025
USD ($)
|
Dec. 31, 2024
USD ($)
|
|---|---|---|---|---|---|---|
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Fair value of long-term debt | $ 29,035 | $ 30,275 | $ 32,182 | $ 38,586 | $ 44,551 | $ 44,765 |
| Estimate of Fair Value Measurement | Pharmakon Term Loans | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Fair value of long-term debt | $ 155,285 | $ 148,828 | ||||
| Measurement Input, Discount Rate | Maximum | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Measurement input | 0.13 | 0.13 |